Fbxw7 regulates tumor apoptosis, growth arrest and the epithelial-to-mesenchymal transition in part through the RhoA signaling pathway in gastric cancer

Cancer Letters

Volumn 370, Issue 1, 2016, Pages 39-55

  Li, Hui ^a   Wang, Ziwei ^a   Zhang, Wei ^a   Qian, Kun ^a   Xu, Wei ^a   Zhang, Shouru ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; EMT; Fbxw7; Gastric cancer; Proliferation; RhoA

Indexed keywords

F BOX AND WD REPEAT DOMAIN CONTAINING 7; F BOX PROTEIN; NERVE CELL ADHESION MOLECULE; PROTEASOME; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SNAIL 1; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; CELL CYCLE PROTEIN; FBXW7 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

ADULT; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CANCER TISSUE; CONTROLLED STUDY; DOWN REGULATION; ENZYME DEGRADATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MIGRATION INHIBITION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; STOMACH CANCER; STOMACH CARCINOGENESIS; TUMOR INVASION; UBIQUITINATION; ANIMAL; BAGG ALBINO MOUSE; CELL MOTION; CELL PROLIFERATION; MORTALITY; MOUSE; PATHOLOGY; PHYSIOLOGY; STOMACH TUMOR; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; F-BOX PROTEINS; HUMANS; MALE; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; RHOA GTP-BINDING PROTEIN; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS; UBIQUITIN-PROTEIN LIGASES;

EID: 84949430615     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2015.10.006     Document Type: Article

References (54)

1. Parkin D.M., Bray F., Ferlay J., Pisani P. Estimating the world cancer burden: Globocan 2000. Int. J. Cancer 2001, 94:153-156.
2. Wang Z., Inuzuka H., Zhong J., Wan L., Fukushima H., Sarkar F.H., et al. Tumor suppressor functions of FBW7 in cancer development and progression. FEBS Lett 2012, 586:1409-1418.
3. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2002, 2:442-454.
4. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
5. Thiery J.P., Sleeman J.P. Complex networks orchestrate epithelial-mesenchymal transitions. Nat. Rev. Mol. Cell Biol 2006, 7:131-142.
6. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev. Cell 2008, 14:818-829.
7. Tarin D., Thompson E.W., Newgreen D.F. The fallacy of epithelial mesenchymal transition in neoplasia. Cancer Res 2005, 65:5996-6000.
8. Chen J., Wang T., Zhou Y.-C., Gao F., Zhang Z.-H., Xu H., et al. Aquaporin 3 promotes epithelial-mesenchymal transition in gastric cancer. J. Exp. Clin. Cancer Res 2014, 33:38.
9. Shi M., Zheng D., Sun L., Wang L., Lin L., Wu Y., et al. XB130 promotes proliferation and invasion of gastric cancer cells. J. Transl. Med 2014, 12:1.
10. Milne A.N., Leguit R., Corver W.E., Morsink F.H.M., Polak M., de Leng W.W., et al. Loss of CDC4/FBXW7 in gastric carcinoma. Cell. Oncol 2010, 32:347-359.
11. Welcker M., Clurman B.E. FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation. Nat. Rev. Cancer 2008, 8:83-93.
12. Cheng Y., Li G. Role of the ubiquitin ligase Fbw7 in cancer progression. Cancer Metastasis Rev 2012, 31:75-87.
13. Tu K., Zheng X., Yin G., Zan X., Yao Y., Liu Q. Evaluation of Fbxw7 expression and its correlation with expression of SREBP-1 in a mouse model of NAFLD. Mol. Med. Rep 2012, 6:525-530.
14. Akhoondi S., Sun D., von der Lehr N., Apostolidou S., Klotz K., Maljukova A., et al. FBXW7/hCDC4 is a general tumor suppressor in human cancer. Cancer Res 2007, 67:9006-9012.
15. Yang H., Lu X., Liu Z., Chen L., Xu Y., Wang Y., et al. FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells. Oncotarget 2015, 6(8):6310-6325.
16. Wang Y., Liu Y., Lu J., Zhang P., Wang Y., Xu Y., et al. Rapamycin inhibits FBXW7 loss-induced epithelial-mesenchymal transition and cancer stem cell-like characteristics in colorectal cancer cells. Biochem. Biophys. Res. Commun 2013, 434:352-356.
17. Zhou J., Hayakawa Y., Wang T.C., Bass A.J. RhoA mutations identified in diffuse gastric cancer. Cancer Cell 2014, 26(1):9-11.
18. Wong C.M., Wei L., Au S.L., Fan D.N., Zhou Y., Tsang F.H., et al. MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis. Oncotarget 2015, 6(15):13658-13670.
19. Nakajima M., Hayashi K., Katayama K., Amano Y., Egi Y., Uehata M., et al. W-f 536 prevents tumor metastasis by inhibiting both tumor motility and angiogenic actions. Eur. J. Pharmacol 2003, 459(2-3):113-120.
20. Wei J., Mialki R.K., Dong S., Khoo A., Mallampalli R.K., Zhao Y., et al. A new mechanism of RhoA ubiquitination and degradation: roles of SCF(FBXL19) E3 ligase and Erk2. Biochim. Biophys. Acta 2013, 1833(12):2757-2764.
21. Drake J.M., Graham N.A., Stoyanova T., Sedghi A., Goldstein A.S., Cai H., et al. Oncogene-specific activation of tyrosine kinase networks during prostate cancer progression. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:1643-1648.
22. Xu M.Z., Yao T.J., Lee N.P., Ng I.O., Chan Y.T., Zender L., et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 2009, 115:4576-4585.
23. Tu K., Zheng X., Zhou Z., Li C., Zhang J., Gao J., et al. Recombinant human adenovirus-p53 injection induced apoptosis in hepatocellular carcinoma cell lines mediated by p53-Fbxw7 pathway, which controls c-Myc and cyclin E. PLoS ONE 2013, 8:e68574.
24. Xu W., Wang Z., Zhang W., Qian K., Li H., Kong D., et al. Mutated K-ras activates CDK8 to stimulate the epithelial-to-mesenchymal transition in pancreatic cancer in part via the Wnt/β-catenin signaling pathway. Cancer Lett 2015, 356(2 Pt B):613-627. pii: S0304-3835(14)00596-5. 10.1016/j.canlet.2014.10.008.
25. Lamouille S., Connolly E., Smyth J.W., Akhurst R.J., Derynck R. TGF-beta-induced activation of mTOR complex 2 drives epithelial-mesenchymal transition and cell invasion. J. Cell Sci 2012, 125:1259-1273.
26. Huang H.L., Weng H.Y., Wang L.Q., Yu C.H., Huang Q.J., Zhao P.P., et al. Triggering Fbw7-mediated proteasomal degradation of c-Myc by oridonin induces cell growth inhibition and apoptosis. Mol. Cancer Ther 2012, 11(5):1155-1165.
27. Wang Z., Liu Y., Zhang P., Zhang W., Wang W., Curr K., et al. FAM83D promotes cell proliferation and motility by downregulating tumor suppressor gene FBXW7. Oncotarget 2013, 4(12):2476-2486.
28. Chen X.M., Guo J.M., Chen P., Mao L.G., Feng W.Y., Le D.H., et al. Suppression of scinderin modulates epithelial-mesenchymal transition markers in highly metastatic gastric cancer cell line SGC-7901. Mol. Med. Rep 2014, 10(5):2327-2333.
29. Zang M., Zhang B., Zhang Y., Li J., Su L., Zhu Z., et al. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway. PLoS ONE 2014, 9(11):e112908.
30. Wang Y., Ngo V.N., Marani M., Yang Y., Wright G., Staudt L.M., et al. Critical role for transcriptional repressor Snail2 in transformation by oncogenic RAS in colorectal carcinoma cells. Oncogene 2010, 29:4658-4670.
31. Bracken C.P., Gregory P.A., Kolesnikoff N., Bert A.G., Wang J., Shannon M.F., et al. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008, 68:7846-7854.
32. Burk U., Schubert J., Wellner U., Schmalhofer O., Vincan E., Spaderna S., et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008, 9:582-589.
33. Onder T.T., Gupta P.B., Mani S.A., Yang J., Lander E.S., Weinberg R.A. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008, 68:3645-3654.
34. Kamai T., Yamanishi T., Shirataki H., Takagi K., Asami H., Ito Y., et al. Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer. Clin. Cancer Res 2004, 10:4799-4805.
35. Pan Y., Bi F., Liu N., Xue Y., Yao X., Zheng Y., et al. Expression of seven main Rho family members in gastric carcinoma. Biochem. Biophys. Res. Commun 2004, 315(3):686-691.
36. Matsumoto A., Tateishi Y., Onoyama I., Okita Y., Nakayama K., Nakayama K.I. Fbxw7β resides in the endoplasmic reticulum membrane and protects cells from oxidative stress. Cancer Sci 2011, 102(4):749-755.
37. Li Y., Chen Y., Tao Y., Xu J., Chen M. RhoA protein is generally distributed in the nuclei of cancer cells. Oncol. Rep 2010, 24:1005-1009.
38. Dubash A.D., Guilluy C., Srougi M.C., Boulter E., Burridge K., García-Mata R. The small GTPase RhoA localizes to the nucleus and is activated by Net1 and DNA damage signals. PLoS ONE 2011, 6:e17380.
39. Guilluy C., Dubash A.D., García-Mata R. Analysis of RhoA and Rho GEF activity in whole cells and the cell nucleus. Nat. Protoc 2011, 6:2050-2060.
40. Burridge K., Wennerberg K. Rho and Rac take center stage. Cell 2004, 116:167-179.
41. Raftopoulou M., Hall A. Cell migration: Rho GTPases lead the way. Dev. Biol 2004, 265:23-32.
42. Yokobori T., Mimori K., Iwatsuki M., et al. p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res 2009, 69:3788-3794.
43. Song Y., Washington M.K., Crawford H.C. Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer. Cancer Res 2010, 70(5):2115-2125.
44. Schmalhofer O., Brabletz S., Brabletz T. E-cadherin, betacatenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 2009, 28:151-166.
45. Tan M., Zhao Y., Kim S.J., Liu M., Jia L., Saunders T.L., et al. SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation. Dev. Cell 2011, 21:1062-1076.
46. Biswas M., Phan D., Watanabe M., Chan J.Y. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis. J. Biol. Chem 2011, 286:39282-39289.
47. Xu J., Li Y., Yang X., Chen Y., Chen M. Nuclear translocation of small G protein RhoA via active transportation in gastric cancer cells. Oncol. Rep 2013, 30(4):1878-1882.
48. Nakayama K.I., Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol 2005, 16:323-333.
49. Wang Z., Li Y., Sarkar F.H. Signaling mechanism(s) of reactive oxygen species in epithelial-mesenchymal transition reminiscent of cancer stem cells in tumor progression. Curr. Stem Cell Res. Ther 2010, 5(1):74-80.
50. Chen X., Ye S., Xiao W., Wang W., Luo L., Liu Y. ERK1/2 pathway mediates epithelial-mesenchymal transition by cross-interacting with TGFβ/Smad and Jagged/Notch signaling pathways in lens epithelial cells. Int. J. Mol. Med 2014, 33(6):1664-1670.
51. Hardy K.M., Booth B.W., Hendrix M.J., Salomon D.S., Strizzi L. ErbB/EGF signaling and EMT in mammary development and breast cancer. J. Mammary Gland Biol. Neoplasia 2010, 15(2):191-199.
52. Jardim D.L., Wheler J.J., Hess K., Tsimberidou A.M., Zinner R., Janku F., et al. FBXW7 mutations in patients with advanced cancers: clinical and molecular characteristics and outcomes with mTOR inhibitors. PLoS ONE 2014, 9(2):e89388.
53. Inuzuka H., Shaik S., Onoyama I., Gao D., Tseng A., Maser R.S., et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011, 471(7336):104-109.
54. Wertz I.E., Kusam S., Lam C., Okamoto T., Sandoval W., Anderson D.J., et al. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7. Nature 2011, 471(7336):110-114.